Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
A unique type of GSK-3 inhibitor brings new opportunities to the clinic.
Licht-Murava A, Paz R, Vaks L, Avrahami L, Plotkin B, Eisenstein M, Eldar-Finkelman H. Licht-Murava A, et al. Among authors: paz r. Sci Signal. 2016 Nov 15;9(454):ra110. doi: 10.1126/scisignal.aah7102. Sci Signal. 2016. PMID: 27902447
GSK-3-TSC axis governs lysosomal acidification through autophagy and endocytic pathways.
Avrahami L, Paz R, Dominko K, Hecimovic S, Bucci C, Eldar-Finkelman H. Avrahami L, et al. Among authors: paz r. Cell Signal. 2020 Jul;71:109597. doi: 10.1016/j.cellsig.2020.109597. Epub 2020 Mar 12. Cell Signal. 2020. PMID: 32173369 Free article.
Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics.
Voloshin T, Schneiderman RS, Volodin A, Shamir RR, Kaynan N, Zeevi E, Koren L, Klein-Goldberg A, Paz R, Giladi M, Bomzon Z, Weinberg U, Palti Y. Voloshin T, et al. Among authors: paz r. Cancers (Basel). 2020 Oct 17;12(10):3016. doi: 10.3390/cancers12103016. Cancers (Basel). 2020. PMID: 33080774 Free PMC article.
Feedback